Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mediwound Ltd Ord Sh (NQ: MDWD )

18.37 +0.27 (+1.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Mediwound Ltd Ord Sh

< Previous 1 2 3 Next >
MDWD Stock Earnings: MediWound Misses EPS, Beats Revenue for Q2 2024
MDWD stock results show that MediWound missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
Via Benzinga
US Stocks Mixed; Jobs Figures Top Estimates For June
Via Benzinga
Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after the company announced it received two purchase orders for a total of approximately one million... 
Via Benzinga
Preview: MediWound's Earnings
Via Benzinga
Recap: MediWound Q3 Earnings
Via Benzinga
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q1 2024
MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023
MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
Earnings Outlook For MediWound
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for MediWound: Here's What You Need To Know
Via Benzinga
What 4 Analyst Ratings Have To Say About MediWound
Via Benzinga
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S. 
Via Benzinga
Earnings Scheduled For November 21, 2023
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is likely to report quarterly earnings at $0.11 per share on revenue of $149.42 million. 
Via Benzinga
Q4 Stock Predictions: 3 Micro-Cap Stocks Ready to Skyrocket Into 2024
These Q4 micro-cap stocks are the ones to buy in on for long-term growth and returns to any investor's portfolio. 
Via InvestorPlace
Earnings Outlook For MediWound
Via Benzinga
Recap: MediWound Q1 Earnings
Via Benzinga
Earnings Outlook For MediWound
Via Benzinga
5 Analysts Have This to Say About MediWound
Via Benzinga
Preview: MediWound's Earnings
Via Benzinga
3 Micro-Cap Stocks to Buy for Multibagger Returns
These are the micro-cap stocks to buy and they represent companies with decent fundamentals and visibility for robust growth. 
Via InvestorPlace
Earnings Scheduled For May 30, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter. 
Via Benzinga
Starbucks To Rally 11%? Here Are 10 Other Analyst Forecasts For Wednesday
UBS cut Microsoft Corporation (NASDAQ: MSFT) price target from $300 to $250. UBS analyst Karl Keirstead downgraded the stock from Buy to Neutral. Microsoft shares fell 2% to $234.73 in pre-market... 
Via Benzinga
Cowen & Co. Maintains Outperform Rating for MediWound: Here's What You Need To Know
Via Benzinga
FDA Approves MediWound's NexoBrid For Burn Treatment
Via Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Biopharma stocks were not immune to the broader market downturn seen for much of 2022. 
Via Benzinga
Earnings Scheduled For November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Dow Turns Higher; Crude Oil Rises 0.7%
U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday. 
Via Benzinga
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
 Gainers 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.